[go: up one dir, main page]

ES2107420T3 - Resolucion enzimatica de endo-biciclo(2.2.1)-heptan-2-ol y agentes farmaceuticos derivados. - Google Patents

Resolucion enzimatica de endo-biciclo(2.2.1)-heptan-2-ol y agentes farmaceuticos derivados.

Info

Publication number
ES2107420T3
ES2107420T3 ES90312019T ES90312019T ES2107420T3 ES 2107420 T3 ES2107420 T3 ES 2107420T3 ES 90312019 T ES90312019 T ES 90312019T ES 90312019 T ES90312019 T ES 90312019T ES 2107420 T3 ES2107420 T3 ES 2107420T3
Authority
ES
Spain
Prior art keywords
endo
biciclo
heptan
pharmaceutical agents
enzymatic resolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312019T
Other languages
English (en)
Inventor
Nicholas A Saccomano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2107420T3 publication Critical patent/ES2107420T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN PROCESO PARA EL METODO DE TRANSESTERIFICACION MEDIADA DE LA LIPASA PARA LA RESOLUCION OPTICA DEL ENDO-NORBONEOL; DERIVADOS OPTICAMENTE ACTIVOS DEL 5-(3-EXO-BICICLO[2.2.1]HEPT-2YLOXY)-4-METHOXIFENIL)-3, 4, 5 6-TETRAHIDROPYRIMIDIN-2(1H)-ONES; Y UN PROCESO A PASOS Y LOS INTERMEDIARIOS DE LO ANTERIOR.
ES90312019T 1989-11-13 1990-11-02 Resolucion enzimatica de endo-biciclo(2.2.1)-heptan-2-ol y agentes farmaceuticos derivados. Expired - Lifetime ES2107420T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005228 WO1991007501A1 (en) 1989-11-13 1989-11-13 Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents

Publications (1)

Publication Number Publication Date
ES2107420T3 true ES2107420T3 (es) 1997-12-01

Family

ID=22215375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312019T Expired - Lifetime ES2107420T3 (es) 1989-11-13 1990-11-02 Resolucion enzimatica de endo-biciclo(2.2.1)-heptan-2-ol y agentes farmaceuticos derivados.

Country Status (27)

Country Link
EP (2) EP0428302B1 (es)
JP (1) JPH06104661B2 (es)
KR (1) KR930004654B1 (es)
CN (1) CN1040423C (es)
AT (1) ATE158577T1 (es)
AU (3) AU633157B2 (es)
CA (1) CA2029705C (es)
CZ (2) CZ280006B6 (es)
DE (1) DE69031487T2 (es)
DK (1) DK0428302T3 (es)
EG (1) EG19860A (es)
ES (1) ES2107420T3 (es)
FI (1) FI105106B (es)
GR (1) GR3025196T3 (es)
HU (2) HU220962B1 (es)
IE (2) IE904059A1 (es)
IL (5) IL110564A (es)
MY (1) MY104517A (es)
NO (1) NO304838B1 (es)
NZ (1) NZ236037A (es)
PH (1) PH30255A (es)
PL (4) PL165132B1 (es)
PT (1) PT95855B (es)
RU (1) RU2104306C1 (es)
WO (1) WO1991007501A1 (es)
YU (1) YU48413B (es)
ZA (1) ZA909044B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007501A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
US5459067A (en) * 1991-12-06 1995-10-17 Shionogi Seiyaku Kabushiki Kaisha Method for producing optically active norborneol by ester hydrolysis
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
AU673569B2 (en) * 1992-12-02 1996-11-14 Pfizer Inc. Catechol diethers as selective PDE-IV inhibitors
JP3431204B2 (ja) * 1993-04-22 2003-07-28 塩野義製薬株式会社 ノルボルナン型エステル・ヒドロラーゼ
CN1041436C (zh) * 1993-05-07 1998-12-30 佛山市制药一厂 一种稳定冯了性风湿跌打药酒的方法
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
JPH1142095A (ja) * 1997-07-25 1999-02-16 Chisso Corp 新規なオキソジシクロペンタジエンの製造方法
KR100479019B1 (ko) * 1998-05-22 2005-08-29 씨제이 주식회사 캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물
TR200909479T2 (tr) 1999-08-21 2012-02-21 Nycomed Gmbh Sinerjistik kombinasyon.
DE60124616T2 (de) * 2000-05-08 2007-09-13 Pfizer Products Inc., Groton Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
WO2003002511A1 (en) 2001-06-29 2003-01-09 Nikken Chemicals Co., Ltd. Cycloalkenone derivative
ES2194588B1 (es) * 2001-07-13 2004-10-16 Astur Pharma S.A. Precursores opticamente puros de paroxetina.
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP4424697A3 (en) 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) * 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
US4732853A (en) * 1984-11-21 1988-03-22 President And Fellows Of Harvard College Method of making chiral epoxy alcohols
FI875724L (fi) * 1986-04-29 1987-12-28 Pfizer Av kalcium oberoende camp fosfodiesteras-inhibitordepressant.
WO1991007501A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents

Also Published As

Publication number Publication date
NZ236037A (en) 1992-08-26
MY104517A (en) 1994-04-30
CA2029705A1 (en) 1991-05-14
HU215441B (hu) 1999-04-28
PL164202B1 (pl) 1994-06-30
KR930004654B1 (ko) 1993-06-02
PH30255A (en) 1997-02-05
KR910009622A (ko) 1991-06-28
PL292069A1 (en) 1992-04-21
IL110568A0 (en) 1994-11-11
YU214290A (sh) 1992-12-21
PT95855B (pt) 1998-01-30
AU3197993A (en) 1993-04-22
FI922142A0 (fi) 1992-05-12
FI105106B (fi) 2000-06-15
NO921876D0 (no) 1992-05-12
PL287727A1 (en) 1992-02-24
DK0428302T3 (da) 1997-10-13
IL110568A (en) 1995-10-31
HU9802988D0 (en) 1999-11-29
EP0428302B1 (en) 1997-09-24
EG19860A (en) 1996-03-31
ZA909044B (en) 1992-06-24
CN1040423C (zh) 1998-10-28
AU645449B2 (en) 1994-01-13
ATE158577T1 (de) 1997-10-15
PL164457B1 (pl) 1994-07-29
CN1051905A (zh) 1991-06-05
EP0428302A2 (en) 1991-05-22
AU6653590A (en) 1991-05-16
GR3025196T3 (en) 1998-02-27
YU48413B (sh) 1998-07-10
HUT64604A (en) 1994-01-28
CA2029705C (en) 1998-11-24
AU633157B2 (en) 1993-01-21
IL110564A (en) 1998-03-10
DE69031487T2 (de) 1998-02-05
JPH06104661B2 (ja) 1994-12-21
CZ124092A3 (en) 1995-04-12
PL165132B1 (pl) 1994-11-30
CZ280006B6 (cs) 1995-09-13
NO304838B1 (no) 1999-02-22
DE69031487D1 (de) 1997-10-30
HU220962B1 (hu) 2002-07-29
RU2104306C1 (ru) 1998-02-10
EP0801135A1 (en) 1997-10-15
NO921876L (no) 1992-07-10
EP0428302A3 (en) 1992-05-13
PT95855A (pt) 1991-09-13
FI922142L (fi) 1992-05-12
PL292070A1 (en) 1992-04-21
CZ560990A3 (en) 1995-04-12
AU3292093A (en) 1993-04-22
CZ280011B6 (cs) 1995-09-13
IL96261A (en) 1996-12-05
IL96261A0 (en) 1991-08-16
PL164176B1 (pl) 1994-06-30
IE904059A1 (en) 1991-05-22
WO1991007501A1 (en) 1991-05-30
JPH03173871A (ja) 1991-07-29
IL110564A0 (en) 1994-11-11
IE980174A1 (en) 2000-02-23

Similar Documents

Publication Publication Date Title
ES2107420T3 (es) Resolucion enzimatica de endo-biciclo(2.2.1)-heptan-2-ol y agentes farmaceuticos derivados.
FI881315L (fi) Menetelmä 2-(kroman- tai tiokroman-6-yyli)etynyylipyridiinikarboksyylihappojohdannaisten valmistamiseksi, joilla on retiinihapon kaltaista aktiivisuutta
AR244918A1 (es) Un amplificador optico del tipo de fibra activa
AU7549687A (en) Precision laser system useful for ophthalmic surgery
BE896972A (fr) Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques t reversibles de la nonoamine oxydase de type b et leur procede de preparation
MX16067A (es) Derivados de glutaramida espirosustituidos y procedimiento para su preparacion
DK0446826T3 (da) Fremgangsmåde til enzymatisk fremstilling af optisk aktive cyanhydriner
EP0437690A3 (en) Process for asymmetric hydrogenation of alpha-ketocarbonyl-derivatives into optically active alpha-hydroxycarbonyl derivatives
AU644093B2 (en) Optically active epoxycyclohexane derivative, optically active epoxycyclohexanone derivative, and production of said derivatives
DE58908505D1 (de) Faseroptischer Strahlteiler.
FI881075A7 (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
MX9300026A (es) Procedimiento para la preparacion de benzoesteres y benzoacidos.
DK3889A (da) Optisk aktive propandiolderivater
ES2067577T3 (es) Procedimiento para la obtencion de isomeros del 1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de etilo y del 1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de 2-(n-metil-n-fenilmetilamino)etilo.
NO179041C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, racemiske eller optisk aktive isokinolinderivater
AU4942990A (en) Process for producing 2-alkyl- and 2-(substituted alkyl) -4-alkylthio and alkylsulfonyl-benzoic acids and their derivatives
AU3580889A (en) Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid
NO911585L (no) Fremgangsmaate for fremstilling av optisk aktive isomerer av 6-substituerte purinylpiperazinderivater.
PT93437A (pt) Processo para a producao de um ester de acido tetra-hidro-1h-tieno-{3,4-d}- -imidazol-2(3h)-ona-4-ilideno-pentanoico 1,3-substituido
AU7166991A (en) Process for racemization of optically active arylethanolamines
MX163201B (es) Proceso para la preparacion de 2-metil-1,2-hexanodioles opticamente activos
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
FI900626A0 (fi) Menetelmä optisesti aktiivisten 3-tiolanyylisulfonaattiestereiden valmistamiseksi
ITMI920232A1 (it) Procedimento per la preparazione di derivati del glicerolo otticamente attivi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 428302

Country of ref document: ES